196 related articles for article (PubMed ID: 12028256)
1. Urinary antispasmodic use and the risks of ventricular arrhythmia and sudden death in older patients.
Wang PS; Levin R; Zhao SZ; Avorn J
J Am Geriatr Soc; 2002 Jan; 50(1):117-24. PubMed ID: 12028256
[TBL] [Abstract][Full Text] [Related]
2. Risks and benefits of bladder antimuscarinics among elderly residents of Veterans Affairs Community Living Centers.
Moga DC; Carnahan RM; Lund BC; Pendergast JF; Wallace RB; Torner JC; Li Y; Chrischilles EA
J Am Med Dir Assoc; 2013 Oct; 14(10):749-60. PubMed ID: 23639715
[TBL] [Abstract][Full Text] [Related]
3. Benefit-risk assessment of tolterodine in the treatment of overactive bladder in adults.
Garely AD; Burrows L
Drug Saf; 2004; 27(13):1043-57. PubMed ID: 15471509
[TBL] [Abstract][Full Text] [Related]
4. Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs.
de Abajo FJ; Rodríguez LA
Br J Clin Pharmacol; 1999 Mar; 47(3):307-13. PubMed ID: 10215756
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of drugs used to treat urge incontinence.
Guay DR
Clin Pharmacokinet; 2003; 42(14):1243-85. PubMed ID: 14606931
[TBL] [Abstract][Full Text] [Related]
6. Overactive bladder in the elderly: a guide to pharmacological management.
Staskin DR
Drugs Aging; 2005; 22(12):1013-28. PubMed ID: 16363885
[TBL] [Abstract][Full Text] [Related]
7. Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid program.
Yu YF; Nichol MB; Yu AP; Ahn J
Value Health; 2005; 8(4):495-505. PubMed ID: 16091027
[TBL] [Abstract][Full Text] [Related]
8. Discontinuation of treatment using anticholinergic medications in patients with urinary incontinence.
Kalder M; Pantazis K; Dinas K; Albert US; Heilmaier C; Kostev K
Obstet Gynecol; 2014 Oct; 124(4):794-800. PubMed ID: 25198276
[TBL] [Abstract][Full Text] [Related]
9. Challenges in the Pharmacological Management of Nursing Home Residents with Overactive Bladder or Urinary Incontinence.
Zarowitz BJ; Allen C; O'Shea T; Tangalos EG; Berner T; Ouslander JG
J Am Geriatr Soc; 2015 Nov; 63(11):2298-307. PubMed ID: 26503458
[TBL] [Abstract][Full Text] [Related]
10. [Antiarrhythmic therapy in patients with heart failure].
Faber TS; Zehender M
Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
[TBL] [Abstract][Full Text] [Related]
11. Can antiarrhythmic drugs survive survival trials?
Pratt CM; Waldo AL; Camm AJ
Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
[TBL] [Abstract][Full Text] [Related]
12. Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: a meta-analysis.
Harvey MA; Baker K; Wells GA
Am J Obstet Gynecol; 2001 Jul; 185(1):56-61. PubMed ID: 11483904
[TBL] [Abstract][Full Text] [Related]
13. Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study.
Chen HL; Hsiao FY
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):841-8. PubMed ID: 26098410
[TBL] [Abstract][Full Text] [Related]
14. Are we shortchanging frail older people when it comes to the pharmacological treatment of urgency urinary incontinence?
Gibson W; Athanasopoulos A; Goldman H; Madersbacher H; Newman D; Spinks J; Wyndaele JJ; Wagg A
Int J Clin Pract; 2014 Sep; 68(9):1165-73. PubMed ID: 25196247
[TBL] [Abstract][Full Text] [Related]
15. Is drug therapy for urinary incontinence used optimally in long-term care facilities?
Narayanan S; Cerulli A; Kahler KH; Ouslander JG
J Am Med Dir Assoc; 2007 Feb; 8(2):98-104. PubMed ID: 17289539
[TBL] [Abstract][Full Text] [Related]
16. Risk of Injury in Older Adults Using Gastrointestinal Antispasmodic and Anticholinergic Medications.
Spence MM; Karim FA; Lee EA; Hui RL; Gibbs NE
J Am Geriatr Soc; 2015 Jun; 63(6):1197-202. PubMed ID: 26096393
[TBL] [Abstract][Full Text] [Related]
17. Does oxybutynin hydrochloride cause arrhythmia in children with bladder dysfunction?
Ciftci I; Arslan D; Peru H; Cimen D; Oran B; Gunduz M
Med Arch; 2013; 67(3):202-4. PubMed ID: 23848044
[TBL] [Abstract][Full Text] [Related]
18. An investigation of factors predicting the type of bladder antimuscarinics initiated in Medicare nursing homes residents.
Moga DC; Wu Q; Doshi P; Goodin AJ
BMC Geriatr; 2017 Dec; 17(1):295. PubMed ID: 29282013
[TBL] [Abstract][Full Text] [Related]
19. Urinary incontinence: economic burden and new choices in pharmaceutical treatment.
Levy R; Muller N
Adv Ther; 2006; 23(4):556-73. PubMed ID: 17050499
[TBL] [Abstract][Full Text] [Related]
20. Risk of developing life-threatening ventricular arrhythmia associated with tefenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine.
Pratt CM; Hertz RP; Ellis BE; Crowell SP; Louv W; Moyé L
Am J Cardiol; 1994 Feb; 73(5):346-52. PubMed ID: 8109548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
